HIV-associated non-Hodgkin‚s lymphoma: highly active antiretroviral therapy improves remission rate of chemotherapy
- 1 April 1999
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 13 (6), 732-4
- https://doi.org/10.1097/00002030-199904160-00018
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre studyBMJ, 1997
- Low-Dose Compared with Standard-Dose m-BACOD Chemotherapy for Non-Hodgkin's Lymphoma Associated with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1997
- Low dose methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone with zalcitabine in patients with acquired immunodeficiency syndrome-related lymphoma: Effect on human immunodeficiency virus and serum interleukin-6 levels over timeCancer, 1996